Consumer scrutiny of synthetic ingredients has reached a tipping point. Whether it’s preservatives in packaged foods, petroleum-derived compounds in personal care products, or artificial colorants in beverages, shoppers are reading labels and voting with their wallets. For consumer packaged goods companies, this shift is more than a marketing challenge — it’s a supply chain problem that touches sourcing, manufacturing, quality control and regulatory compliance all at once.
The good news is that CPG companies solving these problems are discovering that the manufacturing innovations required to work with natural ingredients may be patentable. What begins as an operational headache can become a source of lasting competitive advantage. Supply chain leaders need to understand this transition and the intellectual property opportunities hiding inside it.
Sourcing gets complicated fast. The supplier base for botanical extracts, plant-derived preservatives and natural colorants is far smaller and more geographically concentrated than the supply chains supporting synthetic ingredients. Key raw materials may come from only a handful of regions worldwide, creating exposure to weather events, geopolitical instability and seasonal availability. Diversifying suppliers for risk-mitigation at best introduces problems and at worst isn’t available. Natural raw materials vary by region and climate, so sourcing from multiple suppliers often means managing batch-to-batch differences in potency, appearance and performance.
Variability is a defining quality-control challenge. Unlike synthetic compounds manufactured to precise molecular specifications, natural ingredients show real differences in color, shelf life, active compound concentration and sensory profile. This variability forces wider specification ranges, additional blending or standardization steps, as well as more sophisticated analytical testing. Companies often end up developing proprietary methods just to normalize ingredient performance across production batches — which is a first opportunity for patenting a competitive advantage.
Reformulation involves more than a one-time ingredient swap. It’s an iterative and often disruptive process The swap requires multiple pilot runs, stability testing and (often) consumer acceptance testing. A formulation that works in the lab may fail shelf-life studies or get negative consumer feedback on taste or texture. Each iteration extends timelines and consumes research and development resources. Meanwhile, manufacturing lines often need retooling because natural ingredients may demand different temperature profiles, mixing speeds or allergen segregation protocols. This change translates to capital expenditure and line downtime that has to be carefully sequenced to avoid disrupting existing product output.
Regulatory ambiguity adds another layer of risk. The U.S. Food and Drug Administration has no formal definition of “natural” for food products. The Federal Trade Commission separately regulates advertising claims. For companies operating across product categories or making consumer-facing reformulation claims, this gap creates real compliance exposure. If operating globally, CPG companies face additional complexity in that many jurisdictions maintain distinct frameworks for natural ingredient classification, labeling and permissible marketing claims.
Finally, the cost of natural ingredients also presents a unique challenge. Natural ingredients frequently cost two to five times more than synthetic equivalents, and scale economies take time to develop.
The operational challenges discussed above represent potential sources of commercially advantageous innovation. When a company develops a novel solution to make natural ingredients work at scale, that solution may be patentable.
When research and development creates specific combinations of natural ingredients or synergistic blends that achieve performance comparable to synthetic alternatives, those compositions may qualify for patent protection. Claims covering specific compositions, concentrations and functional interactions can provide broad protection against competitor imitation.
Process innovations are another rich area. A proprietary cold-extraction technique that preserves bioactive compounds, a fermentation process that improves yield from a plant-based source, or a novel method for standardizing variable natural inputs may each be patented independently of the resulting product. Process patents are especially valuable when the end-product is difficult to reverse-engineer, and the manufacturing method provides a real competitive differentiator.
Because natural ingredient reformulation evolves through multiple cycles, CPG companies should consider filing provisional patent applications early to lock in priority dates. Follow-on provisionals may be used to capture improvements as processes mature. This approach ensures that the final commercial product and the applicable manufacturing methods are adequately protected.
As this transition accelerates industry-wide, competitors are pursuing similar paths, making a defensive position important. A solid patent portfolio deters copying, provides leverage in cross-licensing negotiations, and gives companies a bargaining chip in disputes. The ultimate goal is to build a coordinated patent portfolio covering the key aspects of your reformulation and manufacturing strategy.
The natural ingredients patent landscape is more crowded than many companies appreciate. Before committing to a specific pathway, CPG companies should conduct freedom-to-operate analysis to identify potential blocking patents. Catching third-party patent issues early gives room to design around obstacles or negotiate licenses before significant capital has been committed.
Finally, not every innovation is best protected by a patent. Supplier relationships, sourcing strategies and certain processing know-how may be more effectively guarded as trade secrets. Trade secrets last as long as the commercially valuable information remains confidential and protected by reasonable measures. The choice of pursing trade secret protection should be deliberate, weighing reverse-engineering risk and how long the advantage is likely to last. Moreover, the company must have a clear and defensible trade secret policy in order to ensure protection.
CPG companies managing the natural ingredient transition should keep several principles in mind:
IP counsel. Bring intellectual property counsel into the process early. Patent strategy should be part of the reformulation effort from the start and not an afterthought once manufacturing has begun. Early involvement ensures patentable innovations are identified and documented as they emerge.
Freedom to operate. Conduct FTO searches before making major investments to determine whether a new product or related method can be commercialized without infringing on existing, valid patents held by others. The cost of an early FTO analysis is trivial compared to a forced design-around after scale-up is underway.
Portfolio planning. Layer your intellectual property strategy. Combine patents for core formulations and manufacturing processes with trade secret protection for sourcing relationships and operational know-how that competitors cannot reverse-engineer.
Avoiding getting scooped. File provisional applications to preserve priority. Given how iterative natural ingredient work is, locking in early priority dates while research and development continues is essential.
Diligence. Monitor competitor filings. Understanding what competitors are pursuing from a patent perspective informs both defensive strategy and surfaces potential licensing opportunities or freedom-to-operate risks.
Consumer pressure to move away from synthetic ingredients isn’t going away. For CPG companies, the question is no longer whether to make this transition but how to do it in a way that creates lasting value. The supply chain and manufacturing challenges are real, but so are the opportunities. CPG companies that develop novel processes to source, standardize and manufacture with natural ingredients can patent or otherwise appropriate protect those innovations and build competitive moats that outlast the transition itself.
The winners will be the companies that treat this as a coordinated effort across operations, research and development, and intellectual property, with each function reinforcing the others. In an industry where “natural” has become a consumer expectation, the competitive edge goes to those who can deliver it efficiently and protect the innovations that make it possible.
Mark D. Jenkins and Amy H. Fix are partners at Barnes & Thornburg.
